DXB Media thread., page-33

Many DXB non-holders may have diarrhoea tomorrow due to FOMO, if price moves up because of Nina's recent public interview. How skilfully she has highlighed the market size and ACTION-3 standard of care provided in 11 countries. She also provided eGFR diagnosis for protein content in urine.

She also clarified what what mid-March results means and also provided enough hint on current trail progressing with statement "encouraging data from phase 2" and progression of phase 3 of ACTION-3 and endorsement received from Chinese National Medical Products Administration (NMPA)

Don't be surprise if price moves tomorrow 40%.

Be careful not to engage with idi*t downrapers as they drag down you to their level of understanding (many of these are energy vampires) and I usually click "unfollow" button.